- Home
- GSHD vs HCM Comparison
GSHD vs HCM Comparison
Compare GSHD & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHD
- HCM
- Stock Information
- Founded
- GSHD 2003
- HCM 2000
- Country
- GSHD United States
- HCM Hong Kong
- Employees
- GSHD N/A
- HCM N/A
- Industry
- GSHD Specialty Insurers
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- GSHD Finance
- HCM Health Care
- Exchange
- GSHD Nasdaq
- HCM Nasdaq
- Market Cap
- GSHD 2.7B
- HCM 2.5B
- IPO Year
- GSHD 2018
- HCM N/A
- Fundamental
- Price
- GSHD $102.38
- HCM $14.93
- Analyst Decision
- GSHD Buy
- HCM Hold
- Analyst Count
- GSHD 10
- HCM 1
- Target Price
- GSHD $115.40
- HCM $19.00
- AVG Volume (30 Days)
- GSHD 356.7K
- HCM 112.6K
- Earning Date
- GSHD 04-23-2025
- HCM 03-19-2025
- Dividend Yield
- GSHD 5.77%
- HCM N/A
- EPS Growth
- GSHD 129.07
- HCM N/A
- EPS
- GSHD 1.26
- HCM 0.04
- Revenue
- GSHD $324,757,000.00
- HCM $630,201,000.00
- Revenue This Year
- GSHD $21.00
- HCM $14.86
- Revenue Next Year
- GSHD $26.22
- HCM $19.54
- P/E Ratio
- GSHD $81.31
- HCM $70.04
- Revenue Growth
- GSHD 21.87
- HCM N/A
- 52 Week Low
- GSHD $54.80
- HCM $11.51
- 52 Week High
- GSHD $130.39
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- GSHD 46.69
- HCM 54.62
- Support Level
- GSHD $86.04
- HCM $14.24
- Resistance Level
- GSHD $100.68
- HCM $15.37
- Average True Range (ATR)
- GSHD 6.20
- HCM 0.53
- MACD
- GSHD -0.27
- HCM 0.13
- Stochastic Oscillator
- GSHD 58.64
- HCM 80.02
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.